Start the conversation
With this choppy, news-driven market still driving wild daily swings, it's still not time to go "all in." But adding to or starting positions in strong stocks is a good idea.
We've talked about how to get back in at the right pace – buying in increments, using dollar-cost averaging to lower your cost basis.
As far as what to get into – you can't go wrong with a strong tech leader.
These are the stocks you want to own for years to come. Buying in a little off the bottom won't matter in a few years, when your money has doubled or tripled – or better.
To get that tech leader buy list ready, it means giving each one a thorough checkup to make sure that prior to the correction, it had a great track record of earnings gains.
I've recently given you recommendations on this money-doubling stock and these three high-dividend tech stocks. Today, I want to reveal a tech leader that I feel should be on everyone's watch list. It's a former laggard that became one of the market's top leaders. Along the way, it amassed a market value of roughly $1.4 trillion.
But when it became one of the first in the sector to warn of a sales decline brought on by the coronavirus and exposure to China, the stock got hammered.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.